Compare3 funds · 3 pairs
Picked · 3YTD
Every pair · 3Won · shared
Close to theseFee · YTD
Best of the threeNov 6
  • Lowest cost$ a year on $10kVGT 0.09%
  • Most incometrailing 12-month yieldBBC 1.52%
  • Best 5 yearsper yearVGT +15.6%
  • Smallest drop · 1Yworst fall in the past yearIXJ −10.8%
Measures won2–4IXJ wins · of 6 · 5Y
$10,000 · 5Y$20,649VGT · IXJ $13,862
Lowest cost0.09%VGT · $9 on $10k
Most income1.52%BBC · $152 on $10k
Smallest drop−10.8%IXJ · worst fall in 1Y
Held in common0.0%BBC and IXJ

BBC vs IXJ

5Y
BBC
IXJ
Virtus Biotech Clinical Trials ETF · $34MiShares Global Healthcare ETF · $4.6B
+34.8%3 years · per year$24,485 · $14,818+14.0%
−0.0%5 years · per year$9,995 · $13,862+6.7%
0.65%Expense ratio$65 · $38 on $10k · lower wins0.38%
1.52%12-mo yield$152 · $128 on $10k1.28%
−30.2%Worst dropSmaller wins−10.8%
38.6%VolatilityLower wins16.3%
2–4IXJ wins
$10,000 · 5 yearsAll three, one scale
$10k startVGT $20.6kIXJ $13.9kBBC $10.0kOct 2021Nov 2026
Shared top holdingsBBC · IXJ

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%
End-of-day Nov 6, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

All Three

5Y3 funds
#Trend
1VGTVanguard Information Technology ETFReadDesk0.09%0.44%+1.4%+15.6%+12.1%+28.6%+15.6%−17.5%$154.5B
2BIXJiShares Global Healthcare ETFReadDesk0.38%1.28%+0.1%+17.0%+25.1%+14.0%+6.7%−10.8%$4.6B
3ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.52%+5.6%+11.6%+46.1%+34.8%0.0%−30.2%$34M
End-of-day Nov 6, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs IXJ

5Y
Virtus Biotech Clinical Trials
$9,995
iShares Global Healthcare
$13,862
$5k$10kNov 2021Nov 2026$9,995$13,862$5k$10kNov 2021Nov 2026$9,995$13,862
MeasureBBCIXJ
Fee0.65%0.38%
Cost on $10k a year$65$38
Yield1.52%1.28%
5 years, per year−0.0%+6.7%
3 years, per year+34.8%+14.0%
Worst drop · 1Y−30.2%−10.8%
Volatility · 1Y38.6%16.3%
4–2measures won
IXJ first
0.0%
holdings shared
Nov 6, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

XLK vs VGT

YTD
SPDRXLK
+14.8%
VGTVanguard
+15.6%
Jan 1Nov 6+14.8%+15.6%
+14.8%Year to date+15.6%
0.08% · $8Fee · on $10k a year0.09% · $9
$117BAssets$155B
1–1level
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+31.4%
VIGVanguard
+12.1%
Jan 1Nov 6+31.4%+12.1%
+31.4%Year to date+12.1%
3.0%Yield1.5%
$120BAssets$109B
2–0SCHD wins
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+3.2%
JEPIJ.P. Morgan
+5.3%
Jan 1Nov 6+3.2%+5.3%
+3.2%Year to date+5.3%
12.8%Yield8.1%
$42.6BAssets$46.8B
1–1level
End-of-day Nov 6, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, IXJ, VGT

Today
0.0%most shared, BBC and IXJ
BBCIXJVGT
BBC—0.0%0.0%
IXJ0.0%—0.0%
VGT0.0%0.0%—
End-of-day Nov 6, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$90most kept, IXJ
IXJ$128 − $38 = $90
BBC$152 − $65 = $87
VGT$44 − $9 = $35
KeptFee
End-of-day Nov 6, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com